John Lawrence Walecka
2 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 20 Jun 2011, Latest Intermolecular Form D equity offering on 20 Jun 2011.
Roles
- Redpoint Ventures Managing DirectorOct 1, 1999 to present · “Schedule A: WALECKA, JOHN, LAWRENCE, MANAGING DIRECTOR, since 10/1999, ownership A, control person N”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Intermolecular | Form D equity offering | Redpoint Ventures | strongly supported · board | Jun 20, 2011 | Inference sec.gov |
| Intermolecular | Form D equity offering · $15.0M | Redpoint Ventures | strongly supported · board | Mar 10, 2011 | Inference sec.gov |
| Envia Systems Inc | Form D equity offering · $17.0M | Redpoint Ventures | strongly supported · board | Dec 14, 2010 | Inference sec.gov |
Board seats and vehicles
- Intermolecular board seat on a deal Jun 20, 2011 Inference
- Envia Systems Inc board seat on a deal Dec 14, 2010 Inference
- Schooner Information Technology board seat on a deal Jul 30, 2009 Inference
Timeline
- Jun 20, 2011Form D equity offering in Intermolecular (Redpoint Ventures)
- Mar 10, 2011Form D equity offering in Intermolecular (Redpoint Ventures)
- Dec 14, 2010Form D equity offering in Envia Systems Inc (Redpoint Ventures)
- Oct 1, 1999Joined Redpoint Ventures as Managing Director